Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,548,851 | 1,072,585 | 666,896 | 296,697 | 1,313,149 |
| Depreciation Amortization | 775,945 | 572,583 | 375,992 | 181,783 | 717,322 |
| Income taxes - deferred | -5,628 | -54,899 | -25,696 | -12,723 | -45,452 |
| Accounts receivable | -321,734 | -289,442 | -153,995 | -265,008 | -331,260 |
| Accounts payable and accrued liabilities | 133,653 | 101,235 | 61,826 | 76,990 | 27,208 |
| Other Working Capital | -148,537 | -261,417 | -133,908 | -277,921 | -17,201 |
| Other Operating Activity | 157,332 | 155,671 | 66,333 | 179,983 | 296,281 |
| Operating Cash Flow | $2,139,882 | $1,296,316 | $857,448 | $179,801 | $1,960,047 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,012,330 | -734,056 | -497,993 | -246,258 | -935,535 |
| Net Acquisitions | -366,997 | -193,833 | -157,344 | -90,842 | -65,150 |
| Investing Cash Flow | $-1,379,327 | $-927,889 | $-655,337 | $-337,100 | $-1,000,685 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,028,854 | 957,435 | 798,016 | 328,156 | 346,330 |
| Debt Issued | 2,292 | 225 | 154 | 60 | 6,035 |
| Debt Repayment | -732,874 | -553,045 | -218,285 | -53,495 | -324,855 |
| Common Stock Issued | 49,065 | 46,522 | 20,938 | 2,544 | 94,166 |
| Dividend Paid | -277,176 | -277,176 | -277,176 | N/A | -263,244 |
| Other Financing Activity | -654,922 | -491,782 | -374,986 | -162,318 | -865,971 |
| Financing Cash Flow | $-584,761 | $-317,821 | $-51,339 | $114,947 | $-1,007,539 |
| Exchange Rate Effect | 21,939 | 29,731 | 22,463 | 10,622 | -36,178 |
| Beginning Cash Position | 549,500 | 549,500 | 549,500 | 549,500 | 633,855 |
| End Cash Position | 747,233 | 629,837 | 722,735 | 517,770 | 549,500 |
| Net Cash Flow | $197,733 | $80,337 | $173,235 | $-31,730 | $-84,355 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,139,882 | 1,296,316 | 857,448 | 179,801 | 1,960,047 |
| Capital Expenditure | -1,029,992 | -747,642 | -506,099 | -250,178 | -952,943 |
| Free Cash Flow | 1,109,890 | 548,674 | 351,349 | -70,377 | 1,007,104 |